Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology ( Site 0001) is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology ( Site 0001) has participated in 1 clinical trials.
Therapeutic areas: Renal Impairment.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology ( Site 0001) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology ( Site 0001) has 1 clinical trials on record. Their work covers Renal Impairment.
Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology ( Site 0001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.